Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04670874 · ClinicalTrials.gov registry record
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
A clinical trial of Cutaneous Lymphoma, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- 1,250
- Enrollment target
- 1
- Study location
NCT04670874 is a study of Cutaneous Lymphoma that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 1,250 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04670874, a study of Cutaneous Lymphoma, is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- 1,250 participants
- Enrollment target
- 1
- Study location
Study Summary
This study assesses the quality of life in patients with cutaneous lymphoma diagnosis as it relates to their personal, clinical, and therapeutic information using the Skindex29 questionnaire and also assesses patients' understanding of their diagnosis and need for resources related to their care. Cutaneous lymphomas are a rare type of blood cancers (non-Hodgkin lymphoma) that present in the skin. The information gained from this study, may help researchers improve quality of life in cutaneous lymphoma patients.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
| Start Date | 2023-08-17 |
| Est. Completion | 2034-01-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04670874
The ClinicalTrials.gov registry entry for NCT04670874 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cutaneous Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04670874 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04670874 about?
NCT04670874 is a clinical study titled "Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29". This study assesses the quality of life in patients with cutaneous lymphoma diagnosis as it relates to their personal, clinical, and therapeutic information using the Skindex29 questionnaire and also assesses patients' understanding of their diagnosis and need for resources related to their care. Cu...
What is the current status of trial NCT04670874?
This trial is currently recruiting. The enrollment target is 1,250 participants. The study started on 2023-08-17. Estimated completion is 2034-01-24.
What conditions does trial NCT04670874 study?
This clinical trial studies the following conditions: Cutaneous Lymphoma.
What interventions are being tested in trial NCT04670874?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT04670874?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04670874 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cutaneous Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.